Bank of Montreal vs Heron Therapeutics Inc — how do they compare? Bank of Montreal trades at $180.98 (market cap $124.81B), while Heron Therapeutics Inc trades at $0.46 (market cap $78.91M). The key difference: Bank of Montreal is far larger — about 1581.7× Heron Therapeutics Inc's market cap, and Bank of Montreal pays a 2.77% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BMO | HRTX | |
|---|---|---|
Market Cap | $124.81B | $78.91M |
Sector | Financials | Health |
52-Week High | $180.86 | $2.04 |
52-Week Low | $110.44 | $0.39 |
Dividend Yield | 2.77% | — |
Enterprise Value | — | $176.81M |
Trailing returns across standard periods
Latest headlines on both assets
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →